Impact of stage migration and practice changes on high-risk prostate cancer: results from patients treated with radical prostatectomy over the last two decades

被引:28
作者
Fossati, Nicola [1 ,2 ]
Passoni, Niccolo M. [1 ,3 ]
Moschini, Marco [1 ]
Gandaglia, Giorgio [1 ]
Larcher, Alessandro [1 ]
Freschi, Massimo [4 ]
Guazzoni, Giorgio [5 ]
Sjoberg, Daniel D. [2 ]
Vickers, Andrew J. [2 ]
Montorsi, Francesco [1 ]
Briganti, Alberto [1 ]
机构
[1] IRCCS, Osped San Raffaele, URI, Div Oncol,Unit Urol, Milan, Italy
[2] Mem Sloan Kettering Canc Ctr, Dept Epidemiol & Biostat, New York, NY 10021 USA
[3] Univ Texas SW Med Ctr Dallas, Dept Urol, Dallas, TX 75390 USA
[4] IRCCS, Osped San Raffaele, Dept Pathol, Milan, Italy
[5] Humanitas Univ, Humanitas Clin & Res Ctr, Dept Urol, Milan, Italy
关键词
prostate cancer; high risk; radical prostatectomy; stage migration; cancer recurrence; ADJUVANT RADIOTHERAPY; CANDIDATE; OUTCOMES; THERAPY; TRIAL; MEN;
D O I
10.1111/bju.13125
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Objective To evaluate the impact of year of surgery on clinical, pathological and oncological outcomes of patients with high-risk prostate cancer. Patients and Methods We evaluated 1 033 patients with clinically high-risk prostate cancer, defined as the presence of at least one of the following risk factors: preoperative prostate-specific antigen (PSA) level >20 ng/mL, and/or clinical stage >= T3, and/or biopsy Gleason score >= 8. Patients were treated between 1990 and 2013 at a single institution. The year-by-year trends in clinical and pathological characteristics were examined. Multivariable Cox regression analysis was used to test the relationship between year of surgery and oncological outcomes. Results We observed a decrease over time in the proportion of patients with high-risk disease (preoperative PSA >20 ng/mL or clinical stage cT3). A trend in the opposite direction was seen for biopsy Gleason score >= 8 tumours. We observed a considerable increase in the median number of lymph nodes removed, which was associated with an increased rate of lymph node invasion (LNI). On multivariable Cox regression analysis, year of surgery was associated with a reduced risk of biochemical recurrence (hazard ratio [HR] per 5-year interval 0.90, 95% confidence interval [CI] 0.84-0.96; P = 0.01) and distant metastasis (HR per 5-year interval 0.91, 95% CI 0.83-0.99; P = 0.039), after adjusting for age, preoperative PSA, pathological stage, LNI, surgical margin status, and pathological Gleason score. Conclusions In this single-centre study, an increased diagnosis of localized and less extensive high-grade prostate cancer was observed over the last two decades. Patients with high-risk disease who were selected for radical prostatectomy showed better cancer control over time. Better definitions of what constitutes high-risk prostate cancer among contemporary patients are needed.
引用
收藏
页码:740 / 747
页数:8
相关论文
共 28 条
[21]  
Sundi D, 2013, PROSTATE CANCER P D, V17, P57
[22]   Adjuvant Radiotherapy for Pathological T3N0M0 Prostate Cancer Significantly Reduces Risk of Metastases and Improves Survival: Long-Term Followup of a Randomized Clinical Trial [J].
Thompson, Ian M. ;
Tangen, Catherine M. ;
Paradelo, Jorge ;
Lucia, M. Scott ;
Miller, Gary ;
Troyer, Dean ;
Messing, Edward ;
Forman, Jeffrey ;
Chin, Joseph ;
Swanson, Gregory ;
Canby-Hagino, Edith ;
Crawford, E. David .
JOURNAL OF UROLOGY, 2009, 181 (03) :956-962
[23]   The surgical learning curve for laparoscopic radical prostatectomy: a retrospective cohort study [J].
Vickers, Andrew J. ;
Savage, Caroline J. ;
Hruza, Marcel ;
Tuerk, Ingolf ;
Koenig, Philippe ;
Martinez-Pineiro, Luis ;
Janetschek, Gunther ;
Guillonneau, Bertrand .
LANCET ONCOLOGY, 2009, 10 (05) :475-480
[24]  
Walsh P C, 1988, Important Adv Oncol, P161
[25]   Pathological results and rates of treatment failure in high-risk prostate cancer patients after radical prostatectomy [J].
Walz, Jochen ;
Joniau, Steven ;
Chun, Felix K. ;
Isbarn, Hendrik ;
Jeldres, Claudio ;
Yossepowitch, Ofer ;
Chao-Yu, Hsu ;
Klein, Eric A. ;
Scardino, Peter T. ;
Reuther, Alwyn ;
Van Poppel, Hein ;
Graefen, Markus ;
Huland, Hartwig ;
Karakiewicz, Pierre I. .
BJU INTERNATIONAL, 2011, 107 (05) :765-770
[26]   Adjuvant Radiotherapy Versus Wait-and-See After Radical Prostatectomy: 10-year Follow-up of the ARO 96-02/AUO AP 09/95 Trial [J].
Wiegel, Thomas ;
Bartkowiak, Detlef ;
Bottke, Dirk ;
Bronner, Claudia ;
Steiner, Ursula ;
Siegmann, Alessandra ;
Golz, Reinhard ;
Stoerkel, Stephan ;
Willich, Normann ;
Semjonow, Axel ;
Stoeckle, Michael ;
Ruebe, Christian ;
Rebmann, Udo ;
Kaelble, Tilman ;
Feldmann, Horst Jurgen ;
Wirth, Manfred ;
Hofmannm, Rainer ;
Engenhart-Cabillic, Rita ;
Hinke, Axel ;
Hinkelbein, Wolfgang ;
Miller, Kurt .
EUROPEAN UROLOGY, 2014, 66 (02) :243-250
[27]   Secondary therapy, metastatic progression, and cancer-specific mortality in men with clinically high-risk prostate cancer treated with radical prostatectomy [J].
Yossepowitch, Ofer ;
Eggener, Scott E. ;
Serio, Angel M. ;
Caruer, Brett S. ;
Bianco, Fernando J., Jr. ;
Scardino, Peter T. ;
Eastham, James A. .
EUROPEAN UROLOGY, 2008, 53 (05) :950-959
[28]   Radical prostatectomy for clinically localized, high risk prostate cancer: Critical analysis of risk assessment methods [J].
Yossepowitch, Ofer ;
Eggener, Scott E. ;
Bianco, Fernando J., Jr. ;
Carver, Brett S. ;
Serio, Angel ;
Scardino, Peter T. ;
Eastham, James A. .
JOURNAL OF UROLOGY, 2007, 178 (02) :493-499